Skip to main content

Comparative Evaluation of the Tumor Inhibitory and Antibacterial Activity of Solubilized and Particulate Glucan

  • Chapter
Cancer Chemo- and Immunopharmacology

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 75))

Abstract

A soluble derivative of particulate glucan was prepared and evaluated for its antitumor and antibacterial activity. Intravenous administration of soluble or particulate glucan resulted in significant reduction in the growth of a syngeneic anaplastic mammary carcinoma and melanoma B16 and enhanced survival. Soluble and particulate glucan also significantly enhanced survival of mice infected with Staphylococcus aureus. Hepatosplenomegaly and granuloma formation observed in particulate glucan-treated mice were not observed in the soluble glucan group. It is evident that the soluble glucan initiates significant antitumor and antistaphylococcal activity. The active soluble fraction of particulate glucan may be preferable to particulate glucan in view of inherent facility of parenteral administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Browder W, Jones E, McNamee R, Di Luzio NR (1976) Inhibition of tumor growth by glucan, a nonspecific immunostimulant. Surg Forum 27:134–135

    PubMed  CAS  Google Scholar 

  2. Di Luzio NR, Hoffman EO, Cook JA, Browder W, Mansell PWA (1977) Glucan-induced enhancement in host resistance to experimental tumors. In: Chirigos MA (ed) Control of neoplasia by the modulation of the immune system. Raven, New York, pp 475–499

    Google Scholar 

  3. Di Luzio NR, McNamee R, Browder W, Williams DL (1978) Glucan: Inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models. Cancer Treat Rep 62:1857–1866

    PubMed  Google Scholar 

  4. Di Luzio NR, McNamee R, Jones E, Cook JA, Hoffman EO (1976) The employment of glucan and glucan activated macrophages in the enhancement of host resistance to malignancies in experimental animals. In: Fink MA (ed) The macrophage neoplasia. Academic, New York, pp 181–199

    Google Scholar 

  5. Di Luzio NR, Williams DL (1978) Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect Immun 20:804–810

    PubMed  Google Scholar 

  6. Grisebach H, Ebel J (1978) Phytoalexins, chemical defense substanes of higher plants? Angew Chem [Engl] 17:635–647

    Article  Google Scholar 

  7. Hassid WF, Joslyn MA, McCready RM (1941) The molecular constitution of an insoluble polysaccharide from yeast, Saccharomyces cerevisiae. J Am Chem Soc 63:295–298

    Article  CAS  Google Scholar 

  8. Israel L, Edelstein R (1978) Treatment of cutaneous and subcutaneous metastatic tumor with intralesional glucan. In: Chirigos MA (ed) Immune modulation and control of neoplasia by adjuvant therapy. Raven, New York, pp 244–254

    Google Scholar 

  9. Kokoshis PL, Williams DL, Cook JA, Di Luzio NR (1978) Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 199:1340–1342

    Article  PubMed  CAS  Google Scholar 

  10. Manners DJ, Masson AJ, Patterson JC (1973) The structure of a β-(l–3)-D-glucan from yeast cell walls. Biochem J 135:19–30

    PubMed  CAS  Google Scholar 

  11. Mansell PWA, Ichinose H, Reed RJ, Krementz ET, McNamee R, Di Luzio NR (1975) Macrophage mediated destruction of human malignant cells in vivo. J Natl Cancer Inst 54:571–580

    PubMed  CAS  Google Scholar 

  12. Mansell PWA, Di Luzio NR, McNamee R, Rowden G, Proctor JW (1976) Recognition factors and nonspecific macrophage activation in the treatment of neoplastic disease. Ann NY Acad Sci 277:20–44

    Article  PubMed  CAS  Google Scholar 

  13. Sasaki J, Takasuka N, Chihara G, Maeda YY (1976) Antitumor activity of degraded products of lentinan: Its correlation with molecular weight. Cancer 67:191–195

    CAS  Google Scholar 

  14. Soderhall K, Unestam T (1979) Activation of serum prophenoloxidase in arthropod immunity. The specificity of cell wall glucan activation and activation by purified fungal glycoproteins of crayfish phenoloxidase. J Cancer Micro 25:406–414

    Article  CAS  Google Scholar 

  15. Trevelyvan WE, Proctor DP, Harrison JS (1950) Detection of sugars on paper chromatograms. Nature 166:444–445

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

di Luzio, N.R., Williams, D.L., McNamee, R.B., Malshet, V.G. (1980). Comparative Evaluation of the Tumor Inhibitory and Antibacterial Activity of Solubilized and Particulate Glucan. In: Mathé, G., Muggia, F.M. (eds) Cancer Chemo- and Immunopharmacology. Recent Results in Cancer Research, vol 75. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81491-4_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81491-4_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81493-8

  • Online ISBN: 978-3-642-81491-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics